BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23895011)

  • 1. [Research progress in the structure and fuction of Orthopoxvirus host range genes].
    Liu Z; Liu Y; Shao YM
    Bing Du Xue Bao; 2013 Jun; 29(4):437-41. PubMed ID: 23895011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene.
    Ramsey-Ewing AL; Moss B
    Virology; 1996 Aug; 222(1):75-86. PubMed ID: 8806489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic expression libraries for the identification of cross-reactive orthopoxvirus antigens.
    Miller L; Richter M; Hapke C; Stern D; Nitsche A
    PLoS One; 2011; 6(7):e21950. PubMed ID: 21779357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding orthopoxvirus interference with host immune responses to inform novel vaccine design.
    Pickup DJ
    Expert Rev Vaccines; 2007 Feb; 6(1):87-95. PubMed ID: 17280481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CP77 as the Third Orthopoxvirus SAMD9 and SAMD9L Inhibitor with Unique Specificity for a Rodent SAMD9L.
    Zhang F; Meng X; Townsend MB; Satheshkumar PS; Xiang Y
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30918078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cowpox virus host range gene, CP77, affects phosphorylation of eIF2 alpha and vaccinia viral translation in apoptotic HeLa cells.
    Hsiao JC; Chung CS; Drillien R; Chang W
    Virology; 2004 Nov; 329(1):199-212. PubMed ID: 15476887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the susceptibility of the red fox (Vulpes vulpes) to a vaccinia-rabies recombinant virus and to cowpox virus.
    Boulanger D; Brochier B; Crouch A; Bennett M; Gaskell RM; Baxby D; Pastoret PP
    Vaccine; 1995 Feb; 13(2):215-9. PubMed ID: 7625119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orthopoxvirus species and strain differences in cell entry.
    Bengali Z; Satheshkumar PS; Moss B
    Virology; 2012 Nov; 433(2):506-12. PubMed ID: 22999097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive Immune Response to Vaccinia Virus LIVP Infection of BALB/c Mice and Protection against Lethal Reinfection with Cowpox Virus.
    Shchelkunov SN; Sergeev AA; Yakubitskiy SN; Titova KA; Pyankov SA; Kolosova IV; Starostina EV; Borgoyakova MB; Zadorozhny AM; Kisakov DN; Shulgina IS; Karpenko LI
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of a Cowpox virus mutant lacking host range factor CP77.
    Schuenadel L; Tischer BK; Nitsche A
    Virus Res; 2012 Sep; 168(1-2):23-32. PubMed ID: 22705200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Restriction Factors by Human Genome-Wide RNA Interference Screening of Viral Host Range Mutants Exemplified by Discovery of SAMD9 and WDR6 as Inhibitors of the Vaccinia Virus K1L-C7L- Mutant.
    Sivan G; Ormanoglu P; Buehler EC; Martin SE; Moss B
    mBio; 2015 Aug; 6(4):e01122. PubMed ID: 26242627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.
    Verardi PH; Titong A; Hagen CJ
    Hum Vaccin Immunother; 2012 Jul; 8(7):961-70. PubMed ID: 22777090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping.
    Duraffour S; Lorenzo MM; Zöller G; Topalis D; Grosenbach D; Hruby DE; Andrei G; Blasco R; Meyer H; Snoeck R
    J Antimicrob Chemother; 2015 May; 70(5):1367-80. PubMed ID: 25630650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of A-type inclusion formation enhances cowpox virus replication in mice: implications for orthopoxvirus evolution.
    Kastenmayer RJ; Maruri-Avidal L; Americo JL; Earl PL; Weisberg AS; Moss B
    Virology; 2014 Mar; 452-453():59-66. PubMed ID: 24606683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host range selection of vaccinia recombinants containing insertions of foreign genes into non-coding sequences.
    Smith KA; Stallard V; Roos JM; Hart C; Cormier N; Cohen LK; Roberts BE; Payne LG
    Vaccine; 1993; 11(1):43-53. PubMed ID: 8427036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses.
    Antoine G; Scheiflinger F; Dorner F; Falkner FG
    Virology; 1998 May; 244(2):365-96. PubMed ID: 9601507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunomodulatory proteins of orthopoxviruses].
    Shchelkunov SN
    Mol Biol (Mosk); 2003; 37(1):41-53. PubMed ID: 12624944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinia virus K1L protein mediates host-range function in RK-13 cells via ankyrin repeat and may interact with a cellular GTPase-activating protein.
    Bradley RR; Terajima M
    Virus Res; 2005 Dec; 114(1-2):104-12. PubMed ID: 16039000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus.
    Alcamí A; Symons JA; Collins PD; Williams TJ; Smith GL
    J Immunol; 1998 Jan; 160(2):624-33. PubMed ID: 9551896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of the wild-derived inbred CAST/Ei mouse to infection by orthopoxviruses analyzed by live bioluminescence imaging.
    Americo JL; Sood CL; Cotter CA; Vogel JL; Kristie TM; Moss B; Earl PL
    Virology; 2014 Jan; 449():120-32. PubMed ID: 24418545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.